Our guide on peptides for menopause weight loss addresses considerations unique to female researchers during perimenopause and postmenopause phases
We broke down why in the women's piece
Ozempic is approved only for Type 2 diabetes, not weight loss
Tirzepatide: available and gaining ground Tirzepatide is FDA-approved as Mounjaro (for type 2 diabetes) and Zepbound (for chronic weight management)
No Brasil, a nica formulao de tirzepatida aprovada para venda e uso pela Anvisa o Mounjaro, da farmacutica Eli Lilly, indicado para o tratamento de diabetes tipo 2 e obesidade
If you want to stay off food noise long-term, you need either: A maintenance protocol (staying on low-dose GLP-1 or stacking alternatives) Addressing the underlying drivers (sleep, meal timing, food environment, stress) Accepting that complete discontinuation requires a period of readjustment The good news: the brain adapts